Zosano Pharma Corporation (NASDAQ: ZSAN) Soars 171% After Final Milestone Completed in Long-Term Safety Study of Qtrypta, a Acute Treatment for Migraine Disease
Zosano Pharma Corporation (NASDAQ: ZSAN) operates as a clinical-stage biopharmaceutical company. Shares of the biotech company skyrocketed 171.49%, through trading ...
